Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests

Journal of Hematotherapy and Stem Cell Research

Volumn 6, Issue 6, 1997, Pages 551-561

  Traystman, Monica D ^a   Cochran, Gregory T ^a   Hake, Sara J ^a   Kuszynski, Charles A ^a   Mann, Sally L ^b   Murphy, Barbara J ^b   Pirruccello, Samuel J ^a   Zuvanich, Eleanor ^a   Sharp, John G ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW METASTASIS; BREAST CANCER; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031425289     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1997.6.551     Document Type: Review

References (27)

1. Osborne, M.P. & Rosen, P.P. Detection and management of bone marrow micrometastases in breast cancer. Oncology 8:25, 1994.
2. Ross, A.A., Cooper, B.W., Lazarus, H.M., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993.
3. Joshi, S.S., Novak, D.J., Messbarger, L., et al. Levels of detection of tumor cells in human bone marrow. Bone Marrow Transplant. 6:179, 1990.
4. Passos-Coelho, J.L., Ross, A.A., Moss, T.J., et al. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 85:1138, 1995.
5. Brugger, W., Bross, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
6. Cote, R.J., Rosen, P.P., Lesser, M.L., et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J. Clin. Oncol. 9:1749, 1991.
7. Sharp, J.G., Mann, S.L., Kessinger, A., et al. Detection of occult breast cancer cells in cultured pre-transplantation bone marrow. Symp. on Autologous Bone Marrow Transplant 497 (abstract), 1987.
8. Theocharous, P., Lowdell, M.W., Jones, A.L., et al. Immunocytochemical detection of breast cancer cells: A comparison of three attachment factors. J. Hematother. 6:21, 1997.
9. Datta, Y.H., Adams, P.T., Drobyski, W.R., et al. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J. Clin. Oncol. 12:475, 1994.
10. Fields, K.K., Elfenbein, G.J., Perkins, J.B. High Dose versus Standard Dose Chemotherapy for the Treatment of Breast Cancer: A Review of Current Concepts. In Bone Marrow Transplantation, Foundations for the 21st Century, eds. Sackstein, R., Janson, W.E., Elfenbein, G.J. Ann. NY Acad. Sci. 770: 288, 1995.
11. Kruger, W., Krzizanowski, C., Holweg, M., et al. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J. Cancer Res. Clin. Oncol. 122:679, 1996.
12. Krismann, M., Todt, B., Schroder, J., et al. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J. Clin. Oncol. 13:2769, 1995.
13. Sharp, J.G., Vaughan, W.P., Kessinger, A., et al. Significance of detection of tumor cells in hematopoietic stem cell harvests of patients with breast cancer. In Autologous Bone Marrow Transplant V, eds. Dieke, K.A., Armitage, J.O., and Dieke-Evinger, M.J., 1991, p. 385. 1991.
14. Henry, C., Marbrook, J., Vann, D.C., et al. Limiting dilution analysis. In Selected Methods in Cellular Immunology, eds. Mishell, B.B. & Shugi, S.M. W.H. Freeman & Co., New York, 1980, p. 138.
15. Sharp, J.G. Micrometastases and transplantation. J. Hematother. 5:519, 1996.
16. Vredenburgh, J.J., Silva, O., Tyer, C., et al. A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. J. Hematother. 5:57, 1996.
17. Beutler, E., Gelbart, T. & Kuhl, W. Interference of heparin with the polymerase chain reaction. BioTechniques 9:166, 1990.
18. Quinlan, R.A., Schiller, D.L., Hatzfeld, M., et al. Patterns of expression and organization of cytokeratin intermediate filaments. Ann. NY Acad. Sci. 455:282, 1985.
19. Chelly, J., Maire, P., Gautron, S., et al. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333:858, 1988.
20. Chelly, J., Concordet, J., Kaplan, J., et al. Illegitimate transcription: Transcription of any gene in any cell type. Proc. Natl. Acad. Sci. USA 86:2617, 1989.
21. Sarkar, G. & Sommer, S.S. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science 244:331, 1989.
22. Seiden, M., O'Donnell, M.R., McAfee, S., et al. Keratin 19 (K19) reverse transcription based polymerase chain reaction (RT-PCR) assay detects tumor cells in the peripheral blood (PB), bone marrow (BM), and peripheral blood stem cells (PBSC) of women with poor prognosis breast cancer. Proc. Amer. Soc. Clin. Onc. 15:338 (abstract), 1996.
23. Stadtmauer, E.A., Sickles, C., Mangan, P., et al. Tumor contamination of stem cells and prognosis in G-CSF mobilized peripheral stem cell transplant (PSCT) for responding metastatic breast cancer (MBC). Proc. Amer. Soc. Clin. Onc. 15:339 (abstract), 1996.
24. Jung, R., Lubcke, C., Wagener, C., et al. Reversal of RT-PCR inhibition observed in heparinized clinical specimens. BioTechniques 23:24, 1997.
25. Mattano, L.A., Moss, T.J. & Emerson, S.G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 52:4701, 1992.
26. Sharp, J.G. & Grouse, D.A. Marrow contamination: Detection and significance. In High Dose Cancer Therapy: Pharmacology, Hematopoietics and Stem Cells, Sec 4, Laboratory and Clinical Support for Dose Intensive Therapy, 2nd ed., eds. Armitage, J.O., and Antman, K.H., Williams & Wilkins, Baltimore, 1995, p. 259.
27. Tarantolo, S., Reed, E.C., Murphy, B., et al. Administration of GM-CSF to breast cancer patients mobilizes low numbers of tumor cells into leukapheresis harvests. Int. Soc. Exp. Hematol. 24:1047 (abstract), 1996.